US Bancorp
AVXL icon

US Bancorp’s Anavex Life Sciences AVXL Stock Holding History

US Bancorp’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Sell
5,000
-670
-12% -$1.98K ﹤0.01% 3362
2026
Q1 		$17.4K Buy
5,670
+670
+13% +$2.9K ﹤0.01% 3171
2025
Q4 		$17.8K Sell
5,000
-479
-9% -$2.94K ﹤0.01% 3124
2025
Q3 		$48.8K Sell
5,479
-733
-12% -$7.43K ﹤0.01% 2686
2025
Q2 		$57.3K Buy
6,212
+687
+12% +$5.87K ﹤0.01% 2709
2025
Q1 		$47.4K Sell
5,525
-147
-3% -$1.39K ﹤0.01% 2773
2024
Q4 		$60.9K Buy
5,672
+29
+0.5% +$223 ﹤0.01% 2651
2024
Q3 		$32.1K Buy
5,643
+479
+9% +$2.76K ﹤0.01% 2946
2024
Q2 		$21.8K Sell
5,164
-311
-6% -$1.26K ﹤0.01% 3034
2024
Q1 		$27.9K Buy
5,475
+52
+1% +$293 ﹤0.01% 2956
2023
Q4 		$50.5K Buy
5,423
+259
+5% +$1.78K ﹤0.01% 2671
2023
Q3 		$33.8K Buy
5,164
+4,907
+1,909% +$39.1K ﹤0.01% 2628
2023
Q2 		$2.09K Sell
257
-607
-70% -$5.2K ﹤0.01% 3679
2023
Q1 		$7.4K Buy
864
+658
+319% +$6.57K ﹤0.01% 3392
2022
Q4 		$1.91K Buy
206
+42
+26% +$449 ﹤0.01% 3787
2022
Q3 		$2K Hold
164
– – ﹤0.01% 3799
2022
Q2 		$2K Buy
+164
New +$1.55K ﹤0.01% 3794
2022
Q1 		– Sell
-505
Closed -$9K – 4059
2021
Q4 		$9K Buy
505
+478
+1,770% +$9.08K ﹤0.01% 3448
2021
Q3 		$0 Buy
+27
New +$537 ﹤0.01% 4071

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

US Bancorp's AVXL Position: Q2 2026 in Review

US Bancorp reduced its Anavex Life Sciences (AVXL) stake by 12% in Q2 2026, selling an estimated $1.98K and leaving 5,000 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3362.

US Bancorp first reported a position in AVXL in Q3 2021 and has held it in 19 quarters since. The position peaked at $60.9K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • US Bancorp held 5,000 shares of Anavex Life Sciences worth $12.9K as of Q2 2026.
  • US Bancorp sold 670 Anavex Life Sciences shares in Q2 2026, an estimated $1.98K.
  • Anavex Life Sciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3362 holding.
  • US Bancorp first reported a position in Anavex Life Sciences in Q3 2021 and has held it in 19 quarters since.
  • US Bancorp's Anavex Life Sciences position peaked at $60.9K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.